Cross Country Healthcare (CCRN) Tops Q2 EPS by 8c; Offers Q3 Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.69, $0.08 better than the analyst estimate of $0.61. Revenue for the quarter came in at $540.7 million versus the consensus estimate of $531.7 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2023 EPS of $0.35-$0.45, versus the consensus of $0.50. Cross Country Healthcare sees Q3 2023 revenue of $440-450 million, versus the consensus of $465 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Worried the AI trade has gone too far? Evercore likes these 4 stocks